Receptor Agonist Therapy
GLP-1 receptor agonists are prescription medications that mimic a hormone naturally produced in your intestines. These injections slow gastric emptying and signal satiety to your brain, reducing appetite and food cravings. FDA-approved options include semaglutide and tirzepatide for chronic weight management in adults with obesity or overweight conditions with comorbidities.
These medications bind to GLP-1 receptors in your brain, particularly in areas controlling hunger and satiety. The result is reduced appetite, decreased food cravings, and earlier feelings of fullness during meals. This neuroplasticity allows your brain to relearn appropriate portion sizes.
Your provider administers a small subcutaneous injection, typically in your abdomen, thigh, or upper arm. The injection takes less than a minute to complete. Most patients start with a low dose that gradually increases over several weeks to minimize side effects.
We use the InBody Body Composition Analyzer to track changes in body fat, muscle mass, and visceral fat. This provides a far more accurate measure of success than scale weight alone, ensuring your GLP-1 and HRT programs are optimized for real results.